"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
Additional Neostigmine Methylsulfate Information
- Neostigmine Methylsulfate Drug Interactions Center: neostigmine methylsulfate inj
- Neostigmine Methylsulfate Side Effects Center
- Neostigmine Methylsulfate FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.